Eagle Pass Precision Cancer Center LLC is categorized under Oncologists in Houston, TX and active since 2010.
Eagle Pass Precision Cancer Center LLC was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Oncologists business, which does work in the B2C market, and is classified as a Oncologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Chris Cuong Phan at the company’s single location by writing to 2000 Bagby St Apartment 13430, Houston, Texas TX 77002 or by phoning (361) 991-1007. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Eagle Pass Precision Cancer Center LLC |
| Contact Person: | Chris Cuong Phan |
| Address: | 2000 Bagby St Apartment 13430, Houston, Texas 77002 |
| Phone Number: | (361) 991-1007 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Oncologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Eagle Pass Precision Cancer Center LLC was started in 2010 to provide professional Oncologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Chris Cuong Phan for inquiries that concern Eagle Pass Precision Cancer Center LLC by calling the company number (361) 991-1007, as your correspondence is most welcome. Additionally, the physical location of the single location of Eagle Pass Precision Cancer Center LLC can be found at the coordinates 29.752304,-95.376427 as well as the street address 2000 Bagby St Apartment 13430 in Houston, Texas 77002.
For its online presence, you may visit Eagle Pass Precision Cancer Center LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.